2,7-dimethyl-1,6-dihydro-benzo[1,2-d;3,4-d']diimidazole | 205391-03-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2,7-dimethyl-1,6-dihydro-benzo[1,2-d;3,4-d']diimidazole
• 英文别名: 2,7-Dimethyl-1,6-dihydro-benzo[1,2-d;3,4-d']diimidazol；Imidazo[4,5-e][1,3]benzimidazole, 1,6-dihydro-2,7-dimethyl-；2,7-dimethyl-3,6-dihydroimidazo[4,5-e]benzimidazole
• CAS: 205391-03-3
• 化学式: C₁₀H₁₀N₄
• mdl: MFCD07657202
• 分子量: 186.216
• InChiKey: UHKNZJPNBHKIMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  57.4
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 硫酸 作用下， 生成 2,7-dimethyl-1,6-dihydro-benzo[1,2-d;3,4-d']diimidazole
  参考文献：
  名称：

  Nietzki; Schmidt,L., Chemische Berichte, 1889, vol. 22, p. 1651

  摘要：

  DOI：

文献信息

• METAL COMPLEX, AND USE THEREOF
  申请人：Matsunaga Tadafumi

  公开号：US20090318681A1

  公开（公告）日：2009-12-24

  Provided is a metal complex represented by the following formula (A-1) or (B-1) as a metal complex useful for a redox reaction catalyst or some other article that is excellent in heat resistance and acid resistance:

  以下是一种金属配合物，用以下公式(A-1)或(B-1)表示，该金属配合物可用作氧化还原反应催化剂或其他在耐热性和耐酸性方面表现出色的物品：
• Efros, Zhurnal Obshchei Khimii, 1953, vol. 23, p. 957,959;engl.Ausg.S.995,996
  作者：Efros

  DOI：——

  日期：——
• Alkyl-substituted Benzo[1,2-d:3,4-d' ]diimidazoles. Preparation and Annular Tautomerism
  作者：Shuntaro Mataka、Kazuchika Isomura、Tsuyoshi Sawada、Takehito Tsukinoki、Masashi Tashiro、Kazufumi Takahashi、Akiyoshi Tori-i

  DOI：10.3987/com-97-8020

  日期：——

  The treatment of 4-nitro-5-amino-2,1,3-benzothiadiazole (3) with tin/hydrochloric acid in the presence of a carboxylic acid having a C1-C3 chain gave the corresponding 2,5-dialkylbenzo[1,2-d:3,4-d']diimidazoles (1). When the amount of tin was reduced to a half, 3 afforded only 5-alkylimidazolo[4,5-d]benzothiadiazoles (2). Unsymmetrical dialkyldiimidazoles (1) were obtained from 2 in a second step. Annular tautomers due to NH-proton exchange of the imidazole rings of 1 and 2 could be observed in H-1 NMR spectra in DMSO-d(6) at a low concentration (ca. 5 x 10(-4) M).
• FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS
  申请人：Chen Kevin X.

  公开号：US20130156731A1

  公开（公告）日：2013-06-20

  The present invention relates to novel Fused Tricyclic Compounds, compositions comprising at least one Fused Tricyclic Compound, and methods of using Fused Tricyclic Compounds for treating or preventing a viral infection or a virus-related disorder in a patient.
• FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20170008879A1

  公开（公告）日：2017-01-12

  The present invention relates to novel Fused Tricyclic Compounds, compositions comprising at least one Fused Tricyclic Compound, and methods of using Fused Tricyclic Compounds for treating or preventing a viral infection or a virus-related disorder in a patient.